46th week of 2014 patent applcation highlights part 37 |
Patent application number | Title | Published |
20140334976 | STERILIZER, ORAL CAVITY STERILIZER, STERILIZATION METHOD, STERILIZATION APPARATUS, AND STERILIZER EVALUATION METHOD - It is intended to provide a sterilizer, an oral cavity sterilizer, a sterilization method, a sterilization apparatus, and a sterilizer evaluation method capable of enhancing a sterilization effect. The sterilizer including hydrogen peroxide and a catalase activity inhibitor containing | 2014-11-13 |
20140334977 | STEAM STERILISER - Provided is a steam sterilizer for medical instruments including a feeding system configured to feed a sterilization chamber and including at least one main tank for containing a sterilization fluid; an evacuation system configured to evacuate a discharge fluid from the sterilization chamber; and a purification system configured to draw one of the fluids out of one of the systems and to introduce it into the main tank, and including cleaning means configured to filter the fluid. | 2014-11-13 |
20140334978 | System and Apparatus for a Laboratory Scale Reactor - The present disclosure may include a device for testing catalysts, and a method for controlling the flow rate and temperature parameters during the process. The device may separate mass flow control through heating elements from the mass flow through the sample, as well as separate banks for mixing oxidizing elements, carbon dioxide, and diluent gas as well as reducing agents, nitric oxide, and diluent gas. The device disclosed here may also use mass control units of a sufficiently high speed so as to allow the desired testing conditions. | 2014-11-13 |
20140334979 | Biosensor and Measurement Apparatus for Same - Provided is a biosensor and a measuring device which may be coupled with each other only when the biosensor and the measuring device mach with each other, thereby obtaining reliable measured results. | 2014-11-13 |
20140334980 | DETECTION SENSOR SYSTEMS AND METHODS - Analyte detection systems and devices are provided. In one embodiment, a sensor initially reviews an assay, for instance a test strip, to designate a particular testing sequence. The sensor may calibrate the unit and then identify the particular testing sequence by identifying a color indicator on the test strip. The result is systems and methods to improve the detection of the presence and/or absence of at least one analyte in a sample. | 2014-11-13 |
20140334981 | MICROBEAD ANALYSIS METHOD AND MICROBEAD ANALYZER - Provided is a microbead analysis method for a microbead. The microbead is formed in a columnar shape having a top surface and a bottom surface facing each other, as placed almost in parallel, and a side surface extending therefrom, and carries an identification pattern formed on at least one of the top surface and the bottom surface and a substance immobilized on a surface thereof having affinity to an analyte substance. The method includes detecting fluorescence emitted from the microbead surface due to interaction of the analyte substance with the substance having affinity to the analyte substance from a region including a region of the top surface and the bottom surface where there is no identification pattern formed and the side surface. | 2014-11-13 |
20140334982 | Apparatus for Treating a Gas Stream - An apparatus for treating a gas stream includes a plasma abatement device that has a reaction chamber and a plasma torch for generating a plasma stream for injection into the chamber for treating the gas stream. A first inlet conveys a gas stream into the plasma abatement device for treatment, and a second inlet, in a normal condition of the apparatus, is in flow communication with a source of reagent for conveying a reagent into the plasma device for improving the efficiency of the treatment. In a back-up condition of the apparatus, the second inlet is in flow communication with a gas stream source for conveying a gas stream into the device for treatment. | 2014-11-13 |
20140334983 | Reductant Sensor System - An exhaust treatment fluid system includes a tank housing for storing an exhaust treatment fluid. A suction tube includes a first end positioned within the housing and a second end in communication with a suction port of the housing. An elongated laminar flow device is secured to a discharge port of the housing such that exhaust treatment fluid flows along surfaces thereof as the exhaust treatment fluid is returned to the tank housing. The laminar flow device includes a non-circular cross-section. | 2014-11-13 |
20140334984 | REACTOR FOR PREPARING POLYOLEFIN - The invention relates to a process for preparing polyolefin in a loop reactor. The polymer is prepared by polymerizing olefin monomers in the presence of a catalyst to produce a polyolefin slurry while pumping said slurry through said loop reactor by means of a pump. The present process is characterized in that the catalyst is fed in the loop reactor at a distance to the pump. The invention allows production of the polymer with advantageous properties while leading to fewer blockages of the reactor. | 2014-11-13 |
20140334985 | Process for Upgrading Heavy and Highly Waxy Crude Oil Without Supply of Hydrogen - A continuous process to upgrade heavy crude oil for producing more valuable crude feedstock having high API gravity, low asphaltene content, and high middle distillate yield, low sulfur content, low nitrogen content, and low metal content without external supply of hydrogen and/or catalyst. Heavy crude oil having substantial amount of asphaltene and heavy components is mixed with highly waxy crude oil having large amount of paraffinic components and water to decompose asphaltene compounds and remove sulfur, nitrogen, and metal containing substances under supercritical conditions. Product has higher API gravity, lower asphaltene content, high middle distillate yield, lower sulfur content, lower nitrogen content, and lower metal content to be suitable for conventional petroleum refining process. | 2014-11-13 |
20140334986 | Axial Flow Atomization Module - An exhaust treatment component for treating an engine exhaust including a housing including an inlet and an outlet. A mixing device is located within the housing between the inlet and the outlet, and the mixing device includes a shell communicating with the outlet, a decomposition tube having a first end and a second end, and a flow reversing device disposed proximate the second end. The first end extends from the shell and is configured to receive the exhaust from the inlet, and is configured to receive a reagent exhaust treatment fluid. The second end is positioned within the shell. The flow reversing device is configured to direct a mixture of the exhaust and reagent exhaust treatment fluid in predetermined directions into the shell, the flow reversing device reverses a flow direction of the exhaust back towards the first end of the decomposition tube. | 2014-11-13 |
20140334987 | Axial Flow Atomization Module - An exhaust treatment component for treating an engine exhaust. The component includes a housing including an inlet and an outlet, and a mixing assembly located within the housing between the inlet and the outlet. The mixing assembly includes a decomposition tube having a first end and a second end. The first end is configured to receive the exhaust from the inlet and is configured to receive a reagent exhaust treatment fluid. A flow reversing device is disposed proximate the second end, and the flow reversing device is configured to direct a mixture of the exhaust and reagent exhaust treatment fluid as the mixture exits the second end of the decomposition tube in a direction back toward the first end, wherein the flow reversing device includes a plurality of deflecting members for intermixing the exhaust and reagent exhaust treatment fluid. | 2014-11-13 |
20140334988 | Flow Reversing Exhaust Gas Mixer - An exhaust mixing device for mixing an exhaust produced by an engine with a reagent exhaust treatment fluid that is dosed into the exhaust from a dosing module. The exhaust mixing device includes a decomposition tube having a first end and a second end. The first end of the decomposition tube is configured to receive the exhaust and the reagent exhaust treatment fluid. A flow reversing device is positioned at the second end of the decomposition tube. The flow reversing device includes a plurality of deflecting members that intermix the exhaust and reagent exhaust treatment fluid, and direct the exhaust and reagent exhaust treatment fluid in predetermined directions, wherein the flow reversing device reverses a flow direction of the exhaust back towards the first end of the decomposition tube. | 2014-11-13 |
20140334989 | ZPGM Diesel Oxidation Catalysts and Methods of Making and Using Same - Diesel oxidation ZPGM catalyst systems are disclosed. ZPGM catalyst systems may oxidize toxic gases, such as carbon monoxide, hydrocarbons and nitrogen oxides that may be included in exhaust gases. ZPGM catalyst systems may include: a substrate, a washcoat, and an impregnation layer. The washcoat may include at least one carrier material oxides. The impregnation layer may include at least one ZPGM catalyst, carrier material oxides and OSMs. Suitable known in the art chemical techniques, deposition methods and treatment systems may be employed in order to form the disclosed ZPGM catalyst systems. | 2014-11-13 |
20140334990 | ZPGM Diesel Oxidation Catalyst Systems and Methods Thereof - The present disclosure refers to a plurality of methods employed for production of ZPGM diesel oxidation catalyst systems substantially free of PGM, which may include a substrate, a washcoat, and an impregnation layer. Washcoat may include at least one carrier material oxides. An optional impregnation layer component, which may include at least one ZPGM catalyst. This catalyst system may be free of any oxygen storage material (OSM). Suitable deposition methods and firing systems may be employed in order to form disclosed ZPGM oxidation catalyst systems, which may be able to remove main pollutants from exhaust of diesel engines, by oxidizing toxic gases. | 2014-11-13 |
20140334991 | Thermally or Photochemically Activated Small Molecule Delivery Platform - Thermally or photochemically activated small molecule delivery polymers and platforms enable ‘on-demand’ delivery of a vapor-phase lubricant, such as pentanol or other alcohols, that enable scheduled or as-needed lubrication of MEMS devices, thereby greatly improving the reliability and lifespan of the devices. | 2014-11-13 |
20140334992 | Monolithic Heat Exchanger and Apparatus and Methods for Hydrogenation of a Halosilane - A counter current heat exchanger amenable to fabrication from monolithic materials and particularly useful in corrosive and high temperature environments is described. The heat exchanger uses multiple series of holes bored axially through a monolithic material. Axial holes are bored in adjacent flow paths arranged in closely spaced concentric rings. In operation, counter current flow and heat transfer occurs between multiple adjacent axial flow paths. The heat exchanger design is scaleable over a wide range and particularly useful in reactors for the hydrogenation of halosilanes also using cylindrical heating elements. The design enables a small overall reactor size for a given capacity. | 2014-11-13 |
20140334993 | Electronic Pipette - An electronic pipette comprising a piston actuated in a cylinder by a motor, a control system for carrying out pipette operations, and a user interface for operating the pipette, which user interface comprises a display, wherein the main menu of the user interface comprises a user defined shortcut to a specific pipetting application. | 2014-11-13 |
20140334994 | ZIRCON COMPONENTS - A zircon body for use in glass manufacturing is provided containing zircon grains and an intergranular phase present between the zircon grains The intergranular phase may contain silicon oxide. The body may be exposed to a halide to at least partially remove at least a majority of the silicon oxide contained in the intergranular phase from the outer portion or to at least partially remove the intergranular phase along an outer portion of the component. | 2014-11-13 |
20140334995 | METHODS OF PROCESSING SOLUTIONS OF POTASSIUM SULFATE AND MAGNESIUM SULFATE, METHODS OF PRODUCING POTASSIUM SULFATE, AND RELATED SYSTEMS - Methods of processing an aqueous solution comprising potassium sulfate and magnesium sulfate include crystallizing K | 2014-11-13 |
20140334996 | VENTURI REACTOR AND METHOD FOR PRODUCING USABLE BY PRODUCTS USING VENTURI REACTOR - A process for producing a usable product in a reactor comprising introducing co-reactants comprising a fuel source and oxygen into a first section through an inlet, the fuel source comprising carbon; combusting at least a portion of the fuel source and oxygen in an exothermic reaction in the first section using a burner; transferring the co-reactants through a second section that includes a throat having a size that is smaller than a size of the first section, such that a vacuum is induced and a velocity of the co-reactants increases; transferring the co-reactants into a third section that is downstream from the throat and includes an inner wall having a size that is greater than the size of the throat; depositing at least a portion of the uncombusted carbon and a metal oxide along the inner wall, wherein the metal oxide is introduced into at least one of the sections; converting the deposited metal oxide into the usable product in a carbothermic reduction reaction within a molten slag along the inner wall at a temperature of at least 1600° C. | 2014-11-13 |
20140334997 | PROCESS FOR PRODUCING LITHIUM CARBONATE FROM CONCENTRATED LITHIUM BRINE - Disclosed are methods for a simplified process for preparing lithium carbonate from concentrated lithium brine which can be used for battery grade, pharmaceutical and other high purity grade applications. Impure lithium carbonate is precipitated from lithium concentrated brine, preferably lowered in magnesium, subsequently suspended in aqueous solution and reacted with carbon dioxide to form dissolved lithium bicarbonate. The insoluble impurities are filtered and the dissolved boron and metal impurities such calcium, magnesium and iron are physically separated from the lithium bicarbonate solution using ion selective mediums or other selective processes. Lithium carbonate is then subsequently precipitated. | 2014-11-13 |
20140334998 | MATERIAL SUCH AS FILM, FIBER, WOVEN AND NONWOVEN FABRIC WITH ADSORBANCY - Compositions that can be used to adsorb low concentration, of unwanted or target substances from a dynamic fluid stream or from an enclosed static vapor phase. Such adsorbency can be obtained with thermoplastic materials used in the form of bulk polymer or a film, fiber, web, woven fabric, non-woven fabric, sheet, packaging and other such structures including or surrounding the enclosed volume. The concentration should be reduced to non-offensive sensed limits or a limit that does not produce a biological response. | 2014-11-13 |
20140334999 | METHOD FOR TREATING A SUBSTANCE WITH WAVE ENERGY FROM AN ELECTRICAL ARC AND A SECOND SOURCE - A substance is treated using a device having: (a) a volute or cyclone head, (b) a throat connected to the volute or cyclone head, (c) a parabolic reflector connected to the throat, (d) a first wave energy source comprising a first electrode within the volute or cyclone head that extends through the outlet into the opening of the throat along the central axis, and a second electrode extending into the parabolic reflector and spaced apart and axially aligned with first electrode, and (e) a second wave energy source disposed inside the throat, embedded within the throat or disposed around the throat. The substance is directed to the inlet of the volute or cyclone head and irradiated with one or more wave energies produced by the first and second wave energy sources as the substance passes through the device. | 2014-11-13 |
20140335000 | Device for Treating an Upstream Flow with a Solid Product and Associated Treatment Method - The device comprises a support ( | 2014-11-13 |
20140335001 | REMOVAL OF HYDROGEN SULFIDE FROM GAS STREAMS - A method for removing hydrogen sulfide from a gas stream in a gas-liquid absorber apparatus having two separate absorption sections and utilizing a first absorber alkali solution stream that is a waste sodium carbonate source from a soda ash production facility and a second absorber alkali solution stream that is a process feed stream from a soda ash production facility. The method is particularly well suited for removing H | 2014-11-13 |
20140335002 | SEPARATING CARBON DIOXIDE AND HYDROGEN SULFIDE FROM A NATURAL GAS STREAM USING CO-CURRENT CONTACTING SYSTEMS - Systems and methods for separating CO | 2014-11-13 |
20140335003 | CARBON DIOXIDE RECOVERY SYSTEM AND OPERATING METHOD THEREOF - A carbon dioxide recovery system includes an absorption tower in which carbon dioxide is absorbed into an absorbing solution then the absorbing solution is output to a regeneration tower in which carbon dioxide is released from the absorbing solution. The regeneration tower outputs the absorbing solution from which carbon dioxide has been released and an exhaust gas included released carbon dioxide and water vapor. In a condensing section the exhaust gas is separated into dioxide gas stream and a condensed water stream. In a mixing section the condensed water is mixed with an amine to a replenishment amine aqueous solution in which the amine is dissolved in the condensed water. In a replenishment section the absorbing solution is mixed with the replenishment amine aqueous solution. | 2014-11-13 |
20140335004 | SCR CATALYST FOR REMOVAL OF NITROGEN OXIDES - The present invention provides for catalysts for selective catalytic reduction of nitrogen oxides. The catalysts comprise metal oxide supporters, vanadium, an active material, and antimony, a promoter that acts as a catalyst for reduction of nitrogen oxides, and at the same time, can promote higher sulfur poisoning resistance and low temperature catalytic activity. The amount of antimony of the catalysts is preferably 0.5-7 wt. %. | 2014-11-13 |
20140335005 | METHOD OF REMOVING SULFUR OXIDES AND NITROGEN OXIDES IN THE FLUE GAS - The present invention discloses a method of removing sulfur oxides and/or nitrogen oxides in a regeneration flue gas emitted from a regenerator of a catalytic cracking plant and recovering the elemental sulfur and an apparatus therefor. | 2014-11-13 |
20140335006 | METHOD FOR PRODUCING TETRAHALOSILANES - A method produces tetrahalosilanes (SiX | 2014-11-13 |
20140335007 | Method for preparing a trihalosilane - A method of preparing a trihalosilane comprising the separate and consecutive steps of (i) contacting a copper catalyst with hydrogen gas and a silicon tetrahalide at a temperature of from 500 to 1400° C. to form a silicon-containing copper catalyst comprising at least 0.1% (w/w) of silicon, wherein the copper catalyst comprises a metal selected from copper and a mixture comprising copper and at least one element selected from gold, magnesium, and platinum; and (ii) contacting the silicon-containing copper catalyst with a hydrogen halide at a temperature of from 100 to 600° C. to form a trihalosilane. | 2014-11-13 |
20140335008 | Method and Apparatus for Preparation of Granular Polysilicon - A process for preparing granular polysilicon using a fluidized bed reactor is disclosed. The upper and lower spaces of the bed are defined as a reaction zone and a heating zone, respectively, with the height of the reaction gas outlet being selected as the reference height. The invention maximizes the reactor productivity by sufficiently providing the heat required and stably maintaining the reaction temperature in the reaction zone, without impairing the mechanical stability of the fluidized bed reactor. This is achieved through electrical resistance heating in the heating zone where an internal heater is installed in a space in between the reaction gas supplying means and the inner wall of the reactor tube, thereby heating the fluidizing gas and the silicon particles in the heating zone. The heat generated in the heating zone is transferred to the reaction zone by supplying the fluidizing gas at such a rate that the silicon particles can be intermixed between the reaction zone and the heating zone in a continuous, fluidized state. | 2014-11-13 |
20140335009 | METHOD AND APPARATUS FOR PRODUCING LONG CARBON NANOTUBES - The present invention is used to produce long carbon nanotubes used, for example, in automobile and/or aircraft industry. An object of the invention is to obtain bundles of multi-walled and well oriented nanotubes of sufficient length and provide stability of continuous nanotubes producing process. The method comprises introducing a carbon-bearing component, a promoter and a precursor of a carbon nanotube growth catalyst in a carrier gas stream to form a mixture of these components; passing said mixture through the a reactor heated to an operating temperature of 1000° C. to 1200° C. and removing nanotubes formed in the reactor into a product receiver. The mixture is fed in the reactor from the bottom upwards at a linear flow velocity of 50 mm/c to 130 mm/c. When the temperature in the reactor reaches said operating temperature, the linear flow velocity of the mixture is decreased to 4-10 mm/c, and the linear flow velocity is increased to 30-130 mm/c at the outlet of the reactor. The apparatus comprises means for introducing the carbon-bearing component, the promoter and the precursor of the carbon nanotube growth catalyst in the carrier gas stream, a vertical reactor with a working chamber, means for heating the working chamber to the operating temperature, means for delivering the mixture to the working chamber of the reactor and means for removing products from the working chamber. The chamber is made of three successive sections, namely a lower inlet | 2014-11-13 |
20140335010 | PROCESS FOR HIGH-YIELD PRODUCTION OF GRAPHENE VIA DETONATION OF CARBON-CONTAINING MATERIAL - A method of producing pristine graphene particles through a one-step, gas-phase, catalyst-free detonation of a mixture of one or more carbon-containing compounds hydrocarbon compounds and one or more oxidizing agents is provided. The detonation reaction occurs very quickly and at relatively high temperature, greater than 3000 K, to generate graphene nanosheets that can be recovered from the reaction vessel, such as in the form of an aerosol. The graphene nanosheets may be stacked in single, double, or triple layers, for example, and may have an average particle size of between about 35 to about 250 nm. | 2014-11-13 |
20140335011 | METHOD FOR PREPARING GRAPHENE - The present invention relates to a method for preparing graphene substantially free of contamination by metallic, magnetic, organic and inorganic impurities, and also to the use of the resulting graphene for the production of transparent electrodes, batteries, electron-acceptor or electron-donor materials, in particular in photovoltaic systems, photovoltaic panels, transistor channels, in particular in electronics, nonlinear emitters or absorbers of infrared photons, current-conducting electrodes, anti-static coatings, chemical detectors, vias and interconnections in electronics, current-conducting cables, and solar cells. | 2014-11-13 |
20140335012 | PROCESS FOR PRODUCING SUPPORTED RUTHENIUM ON SILICA MODIFIED TITANIA AND PROCESS FOR PRODUCING CHLORINE - An object of the invention is to provide a process for producing a supported ruthenium oxide in which silica can be efficiently supported on a titania carrier and a supported ruthenium oxide superior in thermal stability and catalyst lifetime is obtained. Another object of the present invention is to provide a process for stably producing chlorine for a longer time, by using the supported ruthenium oxide obtained by the above-described process. The invention relates to a process for producing a supported ruthenium oxide in which ruthenium oxide and silica are supported on a titania carrier, wherein a titania carrier is brought into contact with an alkoxysilane compound, followed by being dried under a stream of a water vapor-containing gas, then is subjected to a first calcination under an atmosphere of an oxidizing gas, followed by being brought into contact with a ruthenium compound, and then is subjected to a second calcination under an atmosphere of an oxidizing gas. Chlorine is produced by oxidizing hydrogen chloride with oxygen in the presence of the supported ruthenium oxide thus produced, as a catalyst. | 2014-11-13 |
20140335013 | CATALYTIC DEHYDRATION OF ALCOHOLS USING PHASE PURE, CALCINED SINGLE- AND MULTI-SITE HETEROGENEOUS CATALYSTS - The disclosure describes a new class of isomorphously metal-substituted aluminophosphate materials with high phase purity that are capable of performing selective Brönsted acid catalyzed chemical transformations, such as transforming alcohols to olefins, with high conversions and selectivities using mild conditions. Isomorphous substitutions of functional metal ions for both the aluminum ions and the phosphorous ions were successful in various AlPO structures, along with multiple metal substitutions into a single aluminum site and/or a phosphorous site. This invention can be used towards the catalytic conversion of hydroxylated compounds of linear and/or branched moiety with the possibility of being substituted to their respective hydrocarbon products, preferably light olefins containing 2 to 10 carbon atoms, among other chemistries. | 2014-11-13 |
20140335014 | IL-1 ALPHA DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF - The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease. | 2014-11-13 |
20140335015 | NANOPARTICLES COMPRISING METALLIC AND HAFNIUM OXIDE MATERIALS, PREPARATION AND USES THEREOF - The present invention relates to novel nanoparticles which can be advantageously used in the health sector as diagnostic and/or therapeutic agents. Nanoparticles of the invention comprise a metallic material at least partly covered with an hafnium oxide material or embedded therein. When compared to existing products, these nanoparticles offer a remarkable benefit over risk ratio. Specifically, these nanoparticles potentiate the efficiency of known metallic nanoparticles. Indeed, they retain the metal intrinsic properties and are now in addition safely usable in a mammal, in particular in a human being. The invention also relates to methods for producing said nanoparticles, to compositions containing same, and to uses thereof. | 2014-11-13 |
20140335016 | Bacteriophage Gene 3 Protein Compositions and Use as Amyloid Binding Agents - The invention relates to agents and to pharmaceutical compositions for reducing the formation of amyloid and/or for promoting the disaggregation of amyloid proteins. The compositions may also be used to detect amyloid. | 2014-11-13 |
20140335017 | STRONTIUM PHOSPHATE MICROPARTICLE FOR RADIOLOGICAL IMAGING AND THERAPY - This invention relates to strontium-phosphate microparticles that incorporate radioisotopes for radiation therapy and imaging. | 2014-11-13 |
20140335018 | PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED HEMOGLOBIN-BASED THERAPEUTIC AGENT FOR CANCER TARGETING TREATMENT AND DIAGNOSTIC IMAGING - The present invention provides a pharmaceutical composition containing hemoglobin-based therapeutic agent for treating cancer. The hemoglobin moiety can target cancer cells and the therapeutic moiety (i.e. active agent/therapeutic drug) can kill the cancer cells efficiently. The hemoglobin-based therapeutic agent used in the present invention can be used in the treatment of various cancers such as pancreatic cancer, leukemia, head and neck cancer, colorectal cancer, lung cancer, breast cancer, liver cancer, nasopharyngeal cancer, esophageal cancer, prostate cancer, stomach cancer and brain cancer. The composition can be used alone or in combination with other therapeutic agent(s) such as chemotherapeutic agent to give a synergistic effect on cancer treatment, inhibiting metastasis and/or reducing recurrence. The presently claimed hemoglobin-based 5FU-two-dye conjugate and/or hemoglobin-based 5FU-one-dye conjugate can also be used in live-cell imaging and diagnostic imaging. | 2014-11-13 |
20140335019 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND ANALYSIS OF NEUROLOGICAL DISORDERS - Provided herein are compositions and methods for the treatment and analysis of neurological disorders. In particular, provided herein are small molecules targeted to amyloid-β (Aβ) or metal-Aβ species for the treatment, diagnosis, or study of neurological conditions such as Alzheimer's disease (AD) and other diseases and conditions. | 2014-11-13 |
20140335020 | COMPOSITION AND METHOD OF MAKING THE NOVEL POLYMER GEL FOR USE IN DOSIMETER - Normal N-(Hydroxymethyl) acrylamide (PNHMAG) and normoxic N-(Hydroxymethyl) acrylamide (NHMAGAT) polymer gel dosimeters with low toxicity and low cost are invented for radiation treatment planning. A high dose response was displayed in this invention using nuclear magnetic resonance (NMR) and spectrophotometer methods. The response of both types of gels showed an independence of dose rate and radiation energy and a high degree of stability after irradiation. | 2014-11-13 |
20140335021 | Ocular Neostigmine Drops for Diagnosing Myasthenia Gravis - Disclosed is a method for aiding in the diagnosis of myasthenia gravis. Neostigmine, for example one drop of standard intravenous neostigmine solution (2.5 mg/ml) is instilled into each symptomatic or ptotic eye of patients with suspected or probable myasthenia gravis. The patient is later evaluated for possible changes in ptosis. An observable increase of the palpebral fissure height of at least 2 mm, e.g., after 30-60 minutes after neostigmine instillation is considered to be diagnostic. | 2014-11-13 |
20140335022 | METHOD FOR PATIENT SELECTION - The present invention relates to methods useful in the selection of cancer patients suitable for treatment with therapies directed at c-Met. The method employs imaging agents which comprise | 2014-11-13 |
20140335023 | PLASMA KALLIKREIN BINDING PROTEINS - Plasma kallikrein binding proteins and methods of using such proteins are described. | 2014-11-13 |
20140335024 | NANOCARRIERS FOR IMAGING AND THERAPY APPLICATIONS - Nanocarriers and methods of preparation and use of nanocarriers are presented. In some embodiments, a nanocarrier composition comprises an organic liquid comprising a plurality of nanoparticles dispersed therein; and a coating material disposed around the exterior surface of the organic liquid. Biological tissue may be imaged or treated by coming into contact with a nanocarrier composition, and, at least in some embodiments, irradiated. | 2014-11-13 |
20140335025 | TARGETING CORROLES FOR TUMOR TOXICITY AND MRI - Disclosed herein are compositions comprising a targeted corrole nanoparticle; and an acceptable excipient. Also disclosed are compositions comprising a targeted corrole nanoparticle; and an acceptable carrier. Further, disclosed herein are methods of imaging a condition in a subject, comprising providing a composition comprising a targeted corrole nanoparticle; administering an effective amount of the targeted corrole nanoparticle to the subject; and imaging the condition in the subject. In addition, disclosed herein are methods of treating cancer in a subject, comprising providing a composition comprising a targeted corrole nanoparticle; and administering a therapeutically effective dosage of the targeted corrole nanoparticle to the subject. | 2014-11-13 |
20140335026 | Method of Cleaning an Oral Appliance - A method of cleaning an oral appliance allows a dental patient or other oral appliance wearer to clean the appliance while the appliance is in place in the wearer's mouth. The appliance wearer dispenses a quantity of foamed, cleanser formulation into to his or her mouth, swishes the cleanser around in the mouth for a desired amount of time, and then expectorates any remaining cleanser. A cleaning kit for an oral appliance is also provided and includes a mixture of water, hydrogen peroxide, and at least one surfactant in a foam-dispensing bottle. | 2014-11-13 |
20140335027 | HEATINESS AND SALIVARY SECRETORY IMMUNOGLOBULIN - Described herein are methods of assessing the severity of heatiness in a patient, comprising measuring salivary S-IgA levels, which are found to correlate negatively with the degree of heatiness. The invention further provides, i.a., diagnostic kits, methods of treatment, and the use of oral care compositions to treat heatiness. | 2014-11-13 |
20140335028 | HYDROPHOBIC TOOTH WHITENING SYSTEM AND METHODS OF USE - A tooth whitening system comprising a dental tray having a surface operable to confront a tooth surface, and a tooth whitening composition comprising a whitening agent and a hydrophobic polymer carrier. The tooth whitening composition is preferably substantially non-water soluble. A tooth whitening kit is also provided using a dental tray and the tooth whitening composition comprising a whitening composition and a hydrophobic polymer carrier. | 2014-11-13 |
20140335029 | USE OF CYCLOHEXANOL DERIVATIVES AS ANTIMICROBIAL ACTIVE COMPOUNDS - The present invention relates to the use of at least one cyclohexanol derivative of the formula (I) and/or (II) as antimicrobial active compound or as anti-acne, antidandruff, antiperspirant or deodorant active compound, to preparations comprising these compounds, and to specific cyclohexanol derivatives and to a process for the preparation thereof. | 2014-11-13 |
20140335030 | Modular Emulsion-Based Product Differentiation - A micro-scale heterogeneous emulsion is provided. In some examples, the micro-scale heterogeneous emulsion can include at least two internal phases and an external phase. A method of producing a micro-scale heterogeneous emulsion is also disclosed herein. A method of providing a stable, custom cosmetic composition is also disclosed herein. | 2014-11-13 |
20140335031 | LIQUID SOLUTION COMPRISING PEBA - A liquid composition including between 1 and 15 parts by weight of PEBA to 100 parts by weight of solvent, wherein: said solvent includes between 1 and 49% by volume of alcohol low in C | 2014-11-13 |
20140335032 | Consumer Products Comprising Silane-Modified Oils - A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one hydrolysable silyl group covalently bonded to the hydrocarbon chain. The consumer product further comprises a hydroxyl functional organic species and is substantially free of silica particles. | 2014-11-13 |
20140335033 | Consumer Products Comprising Silane-Modified Oils - A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one hydrolysable silyl group covalently bonded to the hydrocarbon chain. The consumer product further comprises a perfume. | 2014-11-13 |
20140335034 | Consumer Products Comprising Silane-Modified Oils - A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one hydrolysable silyl group covalently bonded to the hydrocarbon chain. The consumer product further comprises a preservative. | 2014-11-13 |
20140335035 | Consumer Products Comprising Silane-Modified Oils - A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one hydrolysable silyl group covalently bonded to the hydrocarbon chain. The consumer product further comprises a particulate benefit agent. | 2014-11-13 |
20140335036 | HAIR CARE CONDITIONING COMPOSITION COMPRISING HISTIDINE - A hair care composition having from about from about 0.025% to about 0.25% by weight of the composition of histidine. The hair care composition further includes a gel matrix phase. The gel matrix has from about 0.1% to about 20% of one or more high melting point fatty compounds, from about 0.1% to about 10% of a C22 cationic surfactant system, and at least about 20% of an aqueous carrier, by weight of said hair care composition. The present invention may further comprise a deposition polymer. | 2014-11-13 |
20140335037 | AQUEOUS OXIDIZING COMPOSITION - Present invention relates to an aqueous oxidizing composition comprising at least one oxidizing, at least one alkyl or alkanol amine, urea, at least one carbonate salt and at least one natural triglyceride. Composition comprises furthermore hair dyes. | 2014-11-13 |
20140335038 | METHOD OF STRENGTHENING HAIR FIBRES - Hair can be damaged in a number of ways including exposure to heat, bleaching, use of shampoos and styling products, brushing and combing, and exposure to the environment, for example ultra-violet light. Existing treatments designed to repair damaged hair make use of surface active materials that mask the problem rather than actually repairing the hair. These materials modify fibre feel by changing consumer perceivable fibre sensory cues such as smoothness, may change some measurable physical properties such as hydrophobicity and hydrophilicity, but do not change other physical characteristics such as fibre stiffness, strength or structural integrity. The invention relates to a method of repairing hair fibres using flavonoids, hydrogen peroxide and a peroxidase enzyme. | 2014-11-13 |
20140335039 | NOVEL OIL-IN-WATER EMULSIONS ENRICHED WITH SALT WHICH ARE HIGHLY VISCOUS AND STABLE OVER TIME - Disclosed is a composition in the form of an oil-in-water emulsion, including: 5-55 wt % of an oil phase; 0.025-3.75 wt % of at least one cross-linked anionic polyelectrolyte resulting from the polymerization of partially or completely salified 2-methyl 2-[(1-oxo 2-propenyl)amino]1-propanesulfonic acid, with at least one neutral monomer selected from acrylamide, (2-hydroxy ethyl)acrylate, and N,N-dialkyl arylamides. Each alkyl group includes 1-4 carbon atoms, and at least one monomer, where R is an alkyl radical including 8-20 carbon atoms and n is a number no smaller than one and no larger than twenty, in the presence of a cross-linking agent; 0.025-3.75 wt % of a galactomannan having a degree of substitution of approximately 1/3; 37.5-94.95 wt % of a cosmetically acceptable aqueous phase, the aqueous phase including 1-25 wt % of a salt, the weight ratio between the galactomannan and the cross-linked anionic polyelectrolyte being 1:3 to 3:1. | 2014-11-13 |
20140335040 | METHOD OF PROVIDING CLEANNESS TO HAIR AND/OR SCALP - Disclosed is a method of providing cleanness to hair and/or scalp, for example, providing hair volume and/or providing less oiliness on hair and/or scalp, by applying a hair care composition comprising cationic surfactants, high melting point fatty compounds, metal pyrithione, and metal salts other than metal pyrithiones. | 2014-11-13 |
20140335041 | SHAMPOO COMPOSITIONS AND METHODS OF MAKING SAME - The present invention relates to a shampoo composition and methods of using the same. The shampoo composition includes a silicone grafted tapioca starch, a detersive surfactant, a cationic conditioning polymer, and a carrier. The shampoo composition can provide both conditioning and volume benefits. | 2014-11-13 |
20140335042 | HAIR CARE COMPOSITION COMPRISING SILICONE GRAFTED STARCH - A hair care composition having from about 0.05% to about 15% of silicone grafted tapioca starch. The hair care composition further includes a gel matrix phase. The gel matrix has from about 0.1% to about 20% of one or more high melting point fatty compounds, from about 0.1% to about 10% of a cationic surfactant system, and at least about 20% of an aqueous carrier, by weight of said hair care composition. | 2014-11-13 |
20140335043 | COMPOSITIONS COMPRISING EXTRACTS OF BURSERA SIMARUBA - The present invention relates to a skin care composition comprising an extract of | 2014-11-13 |
20140335044 | SILICONE ELASTOMER PARTICLE AND AN AQUEOUS DISPERSION COMPRISING THE SAME - One of the purposes of the present invention is to provide a silicone elastomer particle and an aqueous dispersion of the silicone elastomer particles, which prevent generation of odor from oxygenation of nonionic surfactants. The present invention provides a silicone elastomer particle having a crosslinking structure formed by an addition reaction of a monovalent aliphatic unsaturated group bonded to a silicon atom and a hydrogen atom bonded to another silicon atom, wherein the silicone elastomer particle contains an antioxidant. Further, present invention provides an aqueous dispersion comprising the silicone elastomer particles, a nonionic surfactant and water. | 2014-11-13 |
20140335045 | bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS THEREOF - A heparin mimicking polymer, its conjugate with bFGF, and method of making and using the same are disclosed. In particular, described herein are conjugates of biologic agents (e.g., bFGF) and heparin mimicking polymers having superior stability while retaining full native activity after a variety of stressors. | 2014-11-13 |
20140335046 | Compositions, Methods and Systems for Regenerative Cosmetics - A method of inducing or promoting hair growth on the scalp of a subject, comprising the steps of (i) providing an ECM composition including at least one ECM material, (ii) administering inciting event means to a target skin location on the subject to induce an inciting event, and (iii) administering a therapeutically effective amount of said ECM composition to the target skin location. In some embodiments, the ECM composition includes at least one additional biologically active agent. | 2014-11-13 |
20140335047 | DRUG DELIVERY PRODUCT AND METHODS - The present invention provides a particulate delivery system comprising an extracted yeast cell wall comprising beta-glucan, a payload molecule and a payload trapping molecule. The invention further provides methods of making and methods of using the particulate delivery system. | 2014-11-13 |
20140335048 | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-- e]pyrimidin-5(1H)-one, Salts Thereof and Methods of Using the Same in Combination Therapy - This disclosure relates, at least in part, to a method of treatment. In one embodiment, the method of treatment comprises administering to a subject in need of such treatment a first therapeutic agent including compound (1): | 2014-11-13 |
20140335049 | QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF - Fraction A of Quil A can be used together with at least one other adjuvant for the preparation of an adjuvant composition, where the included adjuvant components act synergistically to enhance level of immune response and have synergistic immunomodulating activity on the co-administered antigens or immunogens. Other adjuvants can comprise saponins, naturally occurring, synthetic or semisynthetic saponin molecules; e.g. saponins and saponin fractions from Quil A, cell wall skeleton, block polymers, TDM, lipopeptides, LPS and LPS-derivatives, Lipid A from different bacterial species and derivatives thereof, e.g., monophosphoryl lipid A, CpG variants, CT and LT or fractions thereof. | 2014-11-13 |
20140335050 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER - The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-β receptor agonist or an IFN-γ receptor agonist, for the treatment of cancer. | 2014-11-13 |
20140335051 | SYNERGISTIC BIOMOLECULE-POLYMER CONJUGATES - The synergistic biomolecule-polymer conjugates are the long-acting, in vivo controlled continuous-release and hybrid synergy systems of biomolecules that provide increased biological activities and enhanced pharmacological properties for achieving greater therapeutic efficacies. | 2014-11-13 |
20140335052 | COMBINATION THERAPY FOR TREATING HCV INFECTION IN AN HCV-HIV COINFECTED PATIENT POPULATION - The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient that is co-infected with HIV. | 2014-11-13 |
20140335053 | NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN, NY ESO-1 - The present invention discloses the identification and isolation of novel MHC class II epitopes derived from the cancer antigen, NY ESO-1. The novel MHC class II epitopes from NY-EsO-1 are recognized by CD4 | 2014-11-13 |
20140335054 | CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF - The invention in some aspects relates to recombinant adeno-associated viruses useful for targeting transgenes to CNS tissue, and compositions comprising the same, and methods of use thereof. In some aspects, the invention provides methods and compositions for treating CNS-related disorders. | 2014-11-13 |
20140335055 | REGENERATIVE AUTOLOGOUS CELL THERAPIES AND METHODS OF USE - The present novel technology relates to an autologous cell therapy that comprises a pre-determined amount of a processed bone marrow cellular matrix with a pre-determined amount of pre-mixture, where the pre-mixture includes quantities of anticoagulant solution, dextrose and phosphate buffered saline, and methods for production. The present novel technology further relates to a method of using the composition to reduce discogenic pain in humans. | 2014-11-13 |
20140335056 | SUSTAINED RELEASING PHARMACEUTICAL COMPOSITION - The present invention relates to a formulation made from a chitosan, a gelatin, and a phosphate salt can provide a sustained release/maintenance of a therapeutic agent, wherein the phosphate salt is selected from the group consisting of disodium phosphate and ammonium hydrogen phosphate. | 2014-11-13 |
20140335057 | Methods For Culturing Minimally-Passaged Fibroblasts And Uses Thereof - The present invention relates to novel methods of growing at least 100 million minimally-passaged fibroblasts from a small biopsy specimen. The invention includes methods wherein a small biopsy specimen is needed directly into a large tissue culture flask, and passaged so more than three times. | 2014-11-13 |
20140335058 | ASSAY FOR THE PREDICTION OF THERAPEUTIC EFFECTIVENESS OF MESENCHYMAL STROMAL CELLS, AND METHODS OF USING SAME - The invention relates to assays for testing the therapeutic effectiveness of mesenchymal stromal cell (MSC) populations and methods of treating pathologies with passaged and/or frozen and thawed MSC populations. | 2014-11-13 |
20140335059 | STEM CELL-DERIVED NEURAL CELLS FOR CELL THERAPY IN NEUROLOGICAL DISORDERS - The present invention provides methods and uses of neural cells differentiated from adult stem cells of the oral mucosa for cell therapy of neurological and psychiatric diseases and disorders. Methods for direction of differentiation of oral mucosal stem cells into neuronal or neuron supporting cells are also provided. | 2014-11-13 |
20140335060 | Equine Amniotic Membrane-Derived Mesenchymal Stem Cells - The present invention relates to equine amniotic membrane-derived mesenchymal stem cells (eAM-MSCs) and a preparation method thereof. More specifically, the present invention relates to equine amniotic membrane-derived mesenchymal stem cells, which show negative immunological responses to all of the human markers CD19, CD20, CD28, CD31, CD34, CD38, CD41a, CD62L, CD62P and CD200, and positive immunological responses to all of the human markers CD44, CD90 and CD105, and have the ability to be maintained in an undifferentiated state for 14 passages or more and the ability to differentiate into ectoderm, mesoderm and endoderm-derived cells. | 2014-11-13 |
20140335061 | SUPPLEMENTED OIL COMPOSITIONS AND METHODS FOR IMPROVED HEALTH - Disclosed are compositions and methods comprising supplemented oils for improving health, reducing cardiovascular risk factors, or treating certain conditions. | 2014-11-13 |
20140335062 | CO-CULTURED MESENCHYMAL STEM CELLS AND MYOCYTES - Co-culturing of mesenchymal stem cells or tissues comprising mesenchymal stem cells with myocytes or myocyte containing tissues provide for the long term culture and expansion of myocytes. The co-culture gives rise to three-dimensional functioning cardiac tissue grafts or constructs. | 2014-11-13 |
20140335063 | DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING - Disclosed herein are methods and compositions for delivery of engineered nucleases and donor molecules into the genome of a cell. | 2014-11-13 |
20140335064 | HUMAN SKIN EQUIVALENTS EXPRESSING EXOGENOUS POLYPEPTIDES - The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides. | 2014-11-13 |
20140335065 | HUMAN MILK OLIGOSACCHARIDES FOR PREVENTING INJURY AND/OR PROMOTING HEALING OF THE GASTROINTESTINAL TRACT - Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, children, and adults for preventing injury and/or improving the healing of the gastrointestinal tract. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed. | 2014-11-13 |
20140335066 | LACTOBACILLUS PLANTARUM INDUCIA DSM 21379 AS ENHANCER OF CELLULAR IMMUNITY, HYPOCHOLESTEROLEMIC AND ANTI-OXIDATIVE AGENT AND ANTIMICROBIAL AGENT AGAINST CLOSTRIDIUM DIFFICILE - A microorganism strain | 2014-11-13 |
20140335067 | NOVEL USE OF EC-SOD AND METHOD FOR PREPARING THEREOF - A method for treating a disease, particularly asthma and anaphylactic shock, comprises administering to a subject in need thereof an effective amount of an EC-SOD protein or a vector having a polynucleotide encoding thereof. | 2014-11-13 |
20140335068 | NOVEL USE OF EC-SOD FOR TREATING ANGIOGENESIS-MEDIATED EYE DISEASES - A method for treating an angiogenesis-mediated eye disease, includes administering to a subject in need thereof an effective amount of EC-SOD protein, or a vector having a polynucleotide encoding the EC-SOD protein, to treat angiogenesis-mediated eye diseases. | 2014-11-13 |
20140335069 | GLUCOSE-6-PHOSPHATE DEHYDROGENASE ASSAYS - Aspects of embodiments may include methods for automated enzymatic detection of glucose-6-phosphate dehydrogenase (G6PD) activity. Aspects of embodiments may include methods for enzymatic detection of G6PD activity in droplets in oil. Aspects of embodiments may include a system including a droplet actuator. Aspects of embodiments may include a treatment method. | 2014-11-13 |
20140335070 | DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY - The invention relates to dose escalation enzyme replacement therapy using acid sphingomyelinase (ASM) for the treatment of human subjects having acid sphingomyelinase deficiency (ASMD), and, in particular, patients with non-neurological manifestations of Niemann-Pick Disease (NPD), and in certain embodiments, NPD type B. | 2014-11-13 |
20140335071 | Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV - The invention relates to vWF cleaving entities having a molecular weight of 180 kD, 170 kD, 160 kD, 120 kD or 110 kD and an N-terminal amino acid sequence of AAGGILHLELLV, vWF cleaving complexes and methods for their production. | 2014-11-13 |
20140335072 | Method of Treating or Reducing EFP - The present invention is directed to a method of treating or reducing EFP in a patient comprising administering one or multiple low dose injections of collagenase to an area affected by EFP. The invention encompasses methods wherein the dose of collagenase per injection is between about 50 to about 200 ABC units and/or wherein the concentration of collagenase is between about 50 to about 2000 ABC units/milliliter (ml). | 2014-11-13 |
20140335073 | NUTRITION FOR PREVENTION OF INFECTIONS - A nutritional composition comprising a combination of non-digestible oligosaccharides and a product obtained by incubating an aqueous substrate by bifidobacteria and optionally a product obtained by incubating an aqueous substrate by | 2014-11-13 |
20140335074 | METHODS FOR IMPROVING MEDICAL THERAPIES - Methods are provided herein for enhancing the effectiveness of medical therapies by administering agents that suppress a biological damage response that is inducible by the medical therapy administered to a subject. In certain embodiments, a method is provided for administering an anti-senescent cell agent that suppresses a biological response comprising cellular senescence that is induced by the medical therapy. | 2014-11-13 |
20140335075 | IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS - IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are then screened in vitro to assess each replacements compound's efficiency at modulating immune function. Particular replacement compounds are selected for further in vivo validation and dosage/administration optimization. Finally, the replacement compounds are used to treat a wide range of diseases, including inflammatory and autoimmune diseases. | 2014-11-13 |